Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2)

Titel:: Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2)
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Gabriele Multhoff, …, Michael Molls et al.
Zeitschriftentitel:: Clinical Cancer Research
Jahr:: 2020
Sprache:: en
Volltext / DOI:: doi:10.1158/1078-0432.CCR-20-1141
Verlag / Institution:: American Association for Cancer Research
Print-ISSN:: 1078-0432
E-ISSN:: 1557-3265
Status:: Postprint / reviewed
BibTeX

Vorkommen: